China has authorised the emergency use of CoronaVac, a COVID-19 vaccine manufactured by Chinese firm Sinovac, for children aged between 3 and 17 years, Sinovac Chairman Yin Weidong said. "But when......
India has covered enough population with vaccine and infection, but protein vaccines should remain available on payment basis for elderly and those with comorbidities. IMAGE: A healthcare worker......
Homegrown vaccine maker Bharat Biotech will launch its intranasal COVID-19 vaccine iNCOVACC, the first of its kind in India, on January 26, the company's chairman and managing director Krishna Ella......
The World Health Organisation (WHO) has classified the EG.5 strain of the SARS-CoV-2 virus circulating in different parts of the world, including India, as a 'variant of interest' but said it did......
Results from an early-phase clinical trial of a Chinese vaccine candidate, CoronaVac, revealed that the formulation appears safe and induces an antibody response in healthy volunteers aged 18 to 59......
Due to the vacancies 18 chief commissioners are holding additional charges going up to eight in some cases. Amid economic uncertainties owing to the pandemic, the government’s key revenue......
Serum Institute of India has introduced the country's first indigenous tetanus and diphtheria combination vaccine - Td-Vac for adults in the domestic market.This combination vaccine for combating......
An analysis of Budget speeches made by finance ministers over 75 years also offers a glimpse of how low on the priority list healthcare has featured for the political class and policy-makers, which......
Bharat Biotech started work on developing a vaccine against Zika way back in 2014, but the timing of its announcement has created a flutter in the market. When Bharat Biotech recently......